T
Timothy J Wilt
Researcher at University of Minnesota
Publications - 479
Citations - 41016
Timothy J Wilt is an academic researcher from University of Minnesota. The author has contributed to research in topics: Prostate cancer & Randomized controlled trial. The author has an hindex of 94, co-authored 457 publications receiving 36650 citations. Previous affiliations of Timothy J Wilt include Cochrane Collaboration & Agency for Healthcare Research and Quality.
Papers
More filters
Journal ArticleDOI
Remdesivir for Adults With COVID-19 : A Living Systematic Review for American College of Physicians Practice Points.
TL;DR: This living systematic review examines evidence from randomized trials about the effectiveness and harms of remdesivir treatments for adults with suspected or confirmed COVID-19.
Journal ArticleDOI
Clinical outcomes in adults with chronic hepatitis B in association with patient and viral characteristics: A systematic review of evidence.
Brent C Taylor,Jian-Min Yuan,Tatyana Shamliyan,Aasma Shaukat,Robert L. Kane,Timothy J Wilt,Timothy J Wilt +6 more
TL;DR: Evidence from 41 included articles suggested that cirrhosis, higher HBV viral level, and male sex were consistently associated with significantly increased risk of death and liver cancer.
Educating men about prostate cancer screening. A randomized trial of a mailed pamphlet.
TL;DR: Men who received the educational pamphlet were better informed than men in the usual care group, as measured by correct responses to the following three questions about prostate cancer screening: the natural history of prostate cancer, whether treatment lengthens lives of men with early prostate cancer and accuracy of PSA testing.
Treatment of common hip fractures.
Mary Butler,Mary L Forte,Robert L. Kane,Siddharth Joglekar,Sue Duval,Marc F. Swiontkowski,Timothy J Wilt +6 more
TL;DR: Very limited results suggest that subcapital hip fracture patients with total hip replacements have improved patient outcomes over internal fixation, but it is unclear whether these results would continue to hold if the analyses included the full complement of relevant covariates.
Journal ArticleDOI
Major Update: Remdesivir for Adults With COVID-19 : A Living Systematic Review and Meta-analysis for the American College of Physicians Practice Points.
Anjum S. Kaka,Roderick MacDonald,Nancy Greer,Kathryn Vela,Wei Duan-Porter,Adam J. Obley,Timothy J Wilt +6 more
TL;DR: In this article, a previous review of remdesivir for adults with COVID-19, including new meta-analyses of patients with any severity compared with control, showed that a 5-day course may reduce mortality, the need for ventilation and serious adverse events while increasing the percentage of patients who recovered or clinically improved.